RAS/MAPK activation drives resistance to Smo inhibition, metastasis and tumor evolution in Shh pathway-dependent tumors

Aberrant Shh signaling promotes tumor growth in diverse cancers. The importance of Shh signaling is particularly evident in medulloblastoma and basal cell carcinoma (BCC), where inhibitors targeting the Shh pathway component Smoothened (Smo) show great therapeutic promise. However, the emergence of...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cancer Res
Main Authors: Zhao, Xuesong, Ponomaryov, Tatyana, Ornell, Kimberly J., Zhou, Pengcheng, Dabral, Sukriti K., Pak, Ekaterina, Li, Wei, Atwood, Scott X., Whitson, Ramon J., Chang, Anne Lynn S., Li, Jiang, Oro, Anthony E., Chan, Jennifer A., Kelleher, Joseph F., Segal, Rosalind A.
Format: Artigo
Jezik:Inglês
Izdano: 2015
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4558230/
https://ncbi.nlm.nih.gov/pubmed/26130651
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-14-2999-T
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki